
ARE Stock Forecast & Price Target
ARE Analyst Ratings
Bulls say
Alexandria Real Estate is well positioned by its focus on high-quality life science campuses in premier innovation hubs, where management’s strategy to sell non-core assets and reinvest into higher-value mega campuses should improve portfolio quality over time. Leasing fundamentals remain solid, with 3Q26 occupancy at 87.1% and 90.8% including executed leases, while 1.2msf of leasing volume marked the second highest in the company’s history and highlighted durable demand from advanced technology and life science tenants. The company also benefits from meaningful development and redevelopment runway, plus incremental value creation from partial sales like Campus Point, which generated $475mm of proceeds and supports continued growth without materially weakening the balance sheet.
Bears say
Alexandria Real Estate is facing a deteriorating fundamental backdrop as slower life science leasing, tenant move-outs, and developments rolling off capitalization pressure FFO and NAV, with estimates cut to $6.40 per share in 2026, $4.75 in 2027, and $4.77 in 2028. Its earnings outlook is further clouded by a weaker same-store NOI trend that is still expected to remain negative in 2027, while biotech tenants remain vulnerable to funding tightness, regulatory delays, and a subdued capital markets environment. In addition, higher cap rates on asset sales, supply concerns, and competitive first-generation space leasing could weigh on growth, leaving the shares exposed to a lower valuation profile despite the company’s established market footprint.
This aggregate rating is based on analysts' research of Alexandria Real Estate Equities and is not a guaranteed prediction by Public.com or investment advice.
ARE Analyst Forecast & Price Prediction
Start investing in ARE
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Alexandria Real Estate Equities (ARE) Forecast
ARE Analyst Forecast & Price Prediction
Start investing in ARE
Order type
Buy in
Order amount
Est. shares
0 shares